Protagonist Therapeutics Inc (PTGX)

Quick ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash US$ in thousands 97,249 131,121 355,643 172,568 186,727 230,527 235,382 127,686 125,744 152,816 120,237 98,477 123,665 120,542 192,412 83,000 117,358 83,625 146,242 60,215
Short-term investments US$ in thousands 321,664 337,600 208,354 150,067 154,890 90,224 78,019 103,073 111,611 114,621 171,653 206,812 203,235 193,759 161,868 190,476 188,451 110,349 62,423 57,298
Receivables US$ in thousands — — — — — — — — — — — — — — — — — — — —
Total current liabilities US$ in thousands 47,398 44,578 41,578 39,910 21,274 27,867 26,398 23,229 31,179 36,754 40,088 43,456 44,016 39,156 42,973 34,515 40,241 38,563 35,360 36,372
Quick ratio 8.84 10.51 13.56 8.08 16.06 11.51 11.87 9.93 7.61 7.28 7.28 7.03 7.43 8.03 8.24 7.92 7.60 5.03 5.90 3.23

December 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($97,249K + $321,664K + $—K) ÷ $47,398K
= 8.84

The quick ratio of Protagonist Therapeutics Inc has shown a generally increasing trend from March 31, 2020, to December 31, 2024. The quick ratio started at 3.23 on March 31, 2020, and steadily rose to reach its peak at 16.06 on December 31, 2023, reflecting the company's ability to cover its short-term liabilities with its most liquid assets. However, there was a significant drop in the quick ratio to 8.08 on March 31, 2024, followed by fluctuations in subsequent quarters. Overall, the quick ratio has remained relatively healthy, indicating the company's strong liquidity position and ability to meet its short-term obligations efficiently.